Lora T. Mcglade

1 week ago | univadis.es | Lora T. Mcglade

Editado por Lora McGladeCONCLUSIÓN PRÁCTICAEn un estudio con 239.907 mujeres del Nurses’ Health Study (NHS) y el NHS II se examinó el riesgo de enfermedad cardiovascular después de una histerectomía con o sin ovariectomía. En los resultados se mostró un aumento del riesgo de enfermedad cardiovascular entre las participantes que se sometieron a histerectomía antes de los 50 años de edad, con un riesgo un 21 % mayor en las menores de 46 años que no usaban estrógenos.

1 month ago | francais.medscape.com | Lora T. Mcglade

Entre 50 et 60 % des adultes ont des crampes nocturnes dans les jambes qui induisent, chez 20 % d’entre eux, une insomnie et un sentiment de détresse. Or, il n’existe pas de médicaments à la fois sûrs et efficaces. Le magnésium et les inhibiteurs calciques ont un bénéfice limité, la quinine davantage mais avec un risque d’effets secondaires notables.

Jan 8, 2025 | mdedge.com | Lora T. Mcglade

TOPLINE:Among 57,086 older adults, new gabapentin users demonstrated lower fall-related healthcare visits than duloxetine users, with a weighted cumulative incidence of 84.44 vs 158.21 per 1000 person-years at 180 days. Incident gabapentin use showed a 48% lower hazard of falls at 6-month follow-up, with no increase in severe fall-related events.  METHODOLOGY:Researchers conducted a new user, active comparator cohort study using IBM MarketScan Research Databases from January 2014 to December 2021.

Dec 28, 2024 | medscape.com | Lora T. Mcglade

Analysis revealed muscle-building supplement users had higher odds of initiating anabolic-androgenic steroid use by the next survey wave than nonusers.

Dec 10, 2024 | mdedge.com | Lora T. Mcglade

TOPLINE:The association persists even after accounting for adverse pregnancy outcomes. Women who have experienced infertility without fertility treatment show a 25% higher risk for systemic autoimmune rheumatic disease (SARD) up to 9 years after delivery, compared with those without infertility. METHODOLOGY:Population-based cohort study analyzed 568,053 singleton births among 465,078 women aged 18-50 years without pre-existing SARD in Ontario, Canada, from 2012 to 2021.